🧠 High-Dose SSRI Protocol for OCD Simulator

Starting the Same SSRI Two Different Ways

Placeholder lead: one starting dose, two very different destinations ahead.

• 0.5x: Starting dose (placeholder: low starting dose)
• 1-2 wk: Titration interval (placeholder: dose review cadence)
• 1.0x: Depression ceiling (placeholder: standard max)
• 2-3x: OCD ceiling (placeholder: high-dose max)

Placeholder section heading

Placeholder body text: identical low starting dose for both conditions.

Placeholder highlight: paths diverge only after week one.

Placeholder heading two

Placeholder body text: baseline symptom severity assessed before titration.

Standard-Dose Titration for Depression

Placeholder lead: dose rises modestly, response arrives within weeks.

• 1.0x: Target dose (placeholder: standard therapeutic)
• wk 4-6: Response onset (placeholder: typical timeline)
• ~50%: Remission rate (placeholder: monotherapy)
• 1-2: Dose changes (placeholder: typical titration steps)

Placeholder section heading

Placeholder body text: dose reaches standard range by week four.

Placeholder highlight: earlier upswing than OCD path.

Placeholder heading two

Placeholder body text: response curve climbs steadily after onset.

High-Dose Titration for OCD

Placeholder lead: dose climbs well past the depression ceiling.

• 2-3x: Target dose (placeholder: high-dose ceiling)
• slower: Titration pace (placeholder: more steps upward)
• ongoing: Tolerability watch (placeholder: side-effect monitoring)
• 3-5: Dose changes (placeholder: typical titration steps)

Placeholder section heading

Placeholder body text: dose keeps rising past standard depression range.

Placeholder highlight: ceiling roughly 2-3x depression dose.

Placeholder heading two

Placeholder body text: higher receptor occupancy targeted for OCD circuits.

The Extended Response Timeline

Placeholder lead: improvement lags even after the dose ceiling is reached.

• wk 8-12: Response onset (placeholder: delayed vs depression)
• ≥10 wk: Trial length (placeholder: at max tolerated dose)
• after trial: Switch/augment (placeholder: only if inadequate)
• +4-6 wk: Gap vs depression (placeholder: extra wait time)

Placeholder section heading

Placeholder body text: full high-dose trial requires extended patience.

Placeholder highlight: premature switching risks abandoning efficacy.

Placeholder heading two

Placeholder body text: gradual response curve continues climbing late.

Side-by-Side: Dose Ceiling and Timeline

Placeholder lead: two protocols compared directly on one timeline.

• 1.0x: Depression ceiling (placeholder: standard dose)
• 2.5x: OCD ceiling (placeholder: high dose)
• wk 4-6: Depression response (placeholder: earlier onset)
• wk 8-12: OCD response (placeholder: delayed onset)

Placeholder section heading

Placeholder body text: same slider, two divergent curves shown together.

Placeholder highlight: OCD needs higher dose and more patience.

Placeholder heading two

Placeholder body text: clinical takeaway favors adequate trial length.